WVSU Balik Scientist Program concludes, opens new research avenues
By Juliane Judilla The Department of Science and Technology’s (DOST) Balik Scientist Program, hosted by West Visayas State University (WVSU), concluded with an Exit Report Presentation on Tuesday, August 13, at Diversion 21 Hotel, Mandurriao, Iloilo City. Dr. Souvenir D. Tachado, who served from January 15 to July 12, 2024, highlighted significant contributions and achievements

By Staff Writer

By Juliane Judilla
The Department of Science and Technology’s (DOST) Balik Scientist Program, hosted by West Visayas State University (WVSU), concluded with an Exit Report Presentation on Tuesday, August 13, at Diversion 21 Hotel, Mandurriao, Iloilo City.
Dr. Souvenir D. Tachado, who served from January 15 to July 12, 2024, highlighted significant contributions and achievements during his engagement with WVSU.
Dr. Tachado provided a summary of his three-part presentation, noting his activities, including mentoring young researchers, conducting seminars on biotechnology, nanotechnology, and adverse drug reactions, and leading writeshops to turn terminal reports into publishable articles.
He also oversaw consultations and monitoring of faculty researchers.
He shared details about various partnerships and developments he oversaw at the institution.
Dr. Tachado concluded his presentation by emphasizing the potential of the research and innovation ecosystem in the Philippines, noting the need for continuous support.
“By enhancing funding, fostering collaborations, supporting talent development, promoting innovation, and improving research administration, we can unlock the full potential of our scientific community,” Dr. Tachado said.
“I am grateful to DOST for their dedication to advancing science and technology. Together, we can build a competent and innovative Philippines,” he added.
Dr. Souvenir D. Tachado is the president and CEO of Souvie Biodelivery LLC, a drug delivery development company based in Tucson, Arizona, focused on developing engineered exosomes for tissue- and site-specific active pharmaceutical ingredient (API) delivery.
Article Information
Comments (0)
LEAVE A REPLY
No comments yet
Be the first to share your thoughts!
Related Articles

Capiz flooding hits 8.7% of households, PIDS survey finds
Households in rural Capiz were among the hardest hit by flooding in Western Visayas between 2023 and 2024, with 8.7% affected — more than double the regional average — according to a survey by the Philippine Institute for Development Studies (PIDS). Data from the first wave of the Philippines Socioeconomic Panel


